Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Astellas_Pharma
|
| gptkbp:acquisitionYear |
2016
|
| gptkbp:country |
gptkb:Germany
|
| gptkbp:focus |
immunotherapy
|
| gptkbp:foundedIn |
2001
|
| gptkbp:founder |
Ozlem Tureci
Ugur Sahin |
| gptkbp:headquartersLocation |
gptkb:Mainz,_Germany
|
| https://www.w3.org/2000/01/rdf-schema#label |
Ganymed Pharmaceuticals
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
IMAB362
|
| gptkbp:parentCompany |
gptkb:Astellas_Pharma
|
| gptkbp:website |
https://www.ganymedpharmaceuticals.com/
|
| gptkbp:bfsParent |
gptkb:Astellas_Pharma_Inc.
|
| gptkbp:bfsLayer |
7
|